InflaRx ist ein Biotech-Unternehmen aus Jena, das sich mit Hilfe einer Antikörper-Technologie um die Behandlung von Autoimmun- und Entzündungserkrankungen kümmert. Gegründet wurde das an der US-Technologiebörse NASDAQ gelistete Unternehmen 2007.
COMPANY
INVESTOR TERMSHEET
IF0
InflaRx
#BGFL Mood:
Positive
·
#BGFL-Indicator:
Increase
·
Review date:
17.01.2025
LEI:
391200708PAUDLQ31581
SECTOR:
Gesundheit
SUB-SECTOR:
Biotechnologie
NAME
InflaRx
WKN
A2H7A5
ISIN
NL0012661870
TICKER
IF0
INDEX
EXCHANGE
Frankfurt
#BGFL-nes InflaRx: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.
| 17.01.2025 | InflaRx: Spannende Phase |
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
